Meeting
2014 ASCO Annual Meeting
PD-L1 expression in non-clear cell renal cell carcinoma and benign kidney tumors.
Authors
Andre Poisl Fay
Dana-Farber Cancer Institute, Boston, MA
Andre Poisl Fay , Marcella Callea , Kathryn P. Gray , Thai Huu Ho , Jiaxi Song , Ingrid Carvo , Megan E. Lampron , Laurence Albiges , Melissa L. Stanton , David F. McDermott , Michael B. Atkins , Gordon James Freeman , Michelle S. Hirsch , Sabina Signoretti , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Kidney Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4526)
DOI
10.1200/jco.2014.32.15_suppl.4526
Abstract #
4526
Poster Bd #
18
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
PD-L1 expression in non-clear cell renal cell carcinoma.
First Author: André P Fay
Poster
2019 ASCO Annual Meeting
Atezolizumab plus bevacizumab in non-clear cell renal cell carcinoma (NccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (ccRCCsd): Updated results of activity and predictive biomarkers from a phase II study.
First Author: Ronan Flippot
Poster
2019 Genitourinary Cancers Symposium
A phase II study of nivolumab in patients with high-risk biochemically recurrent (BCR) prostate cancer (PCa).
First Author: David Johnson Einstein
Poster
2017 ASCO Annual Meeting
Association of PD-L1 expression with tumor infiltrating immune cells and mutation burden in the high grade neuroendocrine carcinoma of the lung.
First Author: Hye Sook Kim